SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-286603
Filing Date
2019-11-07
Accepted
2019-11-07 07:10:02
Documents
3
Period of Report
2019-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d828896d8k.htm 8-K 18061
2 EX-99.1 d828896dex991.htm EX-99.1 75662
3 GRAPHIC g828896g1106070928848.jpg GRAPHIC 2075
  Complete submission text file 0001193125-19-286603.txt   98002
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 191198111
SIC: 2836 Biological Products, (No Diagnostic Substances)